SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041839
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:52
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alrn-20230630.htm   iXBRL 10-Q 1797487
2 EX-31.1 alrn-ex31_1.htm EX-31.1 17446
3 EX-31.2 alrn-ex31_2.htm EX-31.2 16911
4 EX-32.1 alrn-ex32_1.htm EX-32.1 10875
5 EX-32.2 alrn-ex32_2.htm EX-32.2 9246
  Complete submission text file 0000950170-23-041839.txt   6720073

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alrn-20230630_cal.xml EX-101.CAL 33583
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alrn-20230630_def.xml EX-101.DEF 125034
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alrn-20230630.xsd EX-101.SCH 37243
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alrn-20230630_pre.xml EX-101.PRE 244448
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alrn-20230630_lab.xml EX-101.LAB 345629
54 EXTRACTED XBRL INSTANCE DOCUMENT alrn-20230630_htm.xml XML 1260439
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38130 | Film No.: 231164034
SIC: 2834 Pharmaceutical Preparations